Get started
Author

Davide Tomasini

Observed names: D Tomasini, D. Tomasini, DAVIDE TOMASINI
ORCID: 0000-0002-9007-522X
Observed ORCID: 0000-0002-9007-522X
OpenAlex ID: A5017334623
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
2019 · Andrea Emanuele Guerini, Luca Triggiani, et al. · Cancers · 146
PDF
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis
2019 · Luca Nicosia, Vanessa Figlia, et al. · Clinical & Experimental Metastasis · 40
18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas
2019 · Domenico Albano, Davide Tomasini, et al. · Annals of Nuclear Medicine · 37
Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets
2021 · Chiara Romani, Eliana Bignotti, et al. · Cancers · 34
PDF
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy
2020 · Luca Nicosia, Francesco Cuccia, et al. · Strahlentherapie und Onkologie · 34
Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 Trial
2020 · Marta Maddalo, Paolo Borghetti, et al. · International Journal of Radiation Oncology*Biology*Physics · 29
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent
2020 · Michela Buglione, Barbara Alicja Jereczek-Fossa, et al. · Lung Cancer · 25
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors
2022 · Silvia Codenotti, Daniela Zizioli, et al. · Cells · 23
PDF
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma
2022 · Davide Lombardi, Michele Tomasoni, et al. · Oral Oncology · 21
Metabolic behavior and prognostic role of pretreatment 18F‐FDG PET/CT in gist
2020 · Domenico Albano, Giovanni Bosio, et al. · Asia-Pacific Journal of Clinical Oncology · 16
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab
2020 · Andrea Emanuele Guerini, Paolo Borghetti, et al. · Clinical Lung Cancer · 15
PDF
Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging
2020 · Michele Rigo, Rosario Mazzola, et al. · La radiologia medica · 14
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways
2023 · Chiara Romani, Luigi Lorini, et al. · Scientific Reports · 13
PDF
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice
2020 · Michela Buglione, Luigi Spiazzi, et al. · Radiation Oncology · 13
PDF
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment
2022 · Andrea Emanuele Guerini, Alessandra Tucci, et al. · Cancers · 12
PDF
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance
2021 · Luca Triggiani, Rosario Mazzola, et al. · Medical Oncology · 12
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience
2020 · Alessandro Alghisi, Paolo Borghetti, et al. · Journal of Cancer Research and Clinical Oncology · 12
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment
2020 · Chin Loon Ong, Niccolò Giaj-Levra, et al. · Radiation Oncology · 10
PDF
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study
2022 · Teresa Savarese, Andrea Abate, et al. · Scientific Reports · 9
PDF
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
2021 · Michela Buglione, Daniela Alterio, et al. · Radiation Oncology · 9
PDF
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective
2024 · Marco Lorenzo Bonù, Luca Nicosia, et al. · La radiologia medica · 8
PDF
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
2023 · Paolo Borghetti, Giulia Volpi, et al. · Frontiers in Oncology · 8
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group
2020 · Lilia Bardoscia, Luca Triggiani, et al. · World Journal of Urology · 8
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram
2023 · Vittorio Rampinelli, Marco Ferrari, et al. · Frontiers in Oncology · 7
PDF
Stereotactic Radiotherapy for Critically Located Pancreatic and Biliary Targets: A Review on Simultaneous Integrated Protection and Other Dose-Painting Strategies to Minimize Dose to Critical Organs at Risk
2023 · Marco Lorenzo Bonù, Gloria Pedersoli, et al. · Radiation · 7
PDF
Works count: 62
Citation count: 610
H-index: 13
I10-index: 18
Year
Topic
Type